Raymond James & Associates Dynavax Technologies Corp Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Raymond James & Associates holds 10,125 shares of DVAX stock, worth $125,752. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,125
Holding current value
$125,752
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$10.05 - $11.61 $101,756 - $117,551
10,125 New
10,125 $112,000
Q1 2022

May 11, 2022
SELL
$9.75 - $14.44 $105,768 - $156,645
-10,848 Closed
0 $0
Q4 2021

Feb 08, 2022
BUY
$13.17 - $20.94 $142,868 - $227,157
10,848 New
10,848 $153,000
Q1 2021

May 14, 2021
SELL
$4.57 - $11.18 $236,945 - $579,660
-51,848 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$3.73 - $5.6 $31,854 - $47,824
8,540 Added 19.72%
51,848 $231,000
Q3 2020

Nov 04, 2020
SELL
$4.32 - $11.7 $70,848 - $191,880
-16,400 Reduced 27.47%
43,308 $187,000
Q2 2020

Jul 28, 2020
BUY
$2.94 - $9.1 $175,541 - $543,342
59,708 New
59,708 $530,000
Q3 2019

Nov 07, 2019
SELL
$2.69 - $4.85 $67,726 - $122,108
-25,177 Closed
0 $0
Q2 2019

Aug 06, 2019
SELL
$3.65 - $7.89 $24,184 - $52,279
-6,626 Reduced 20.83%
25,177 $100,000
Q1 2019

May 06, 2019
BUY
$7.08 - $12.09 $20,680 - $35,314
2,921 Added 10.11%
31,803 $232,000
Q4 2018

Feb 11, 2019
SELL
$8.14 - $13.28 $38,095 - $62,150
-4,680 Reduced 13.94%
28,882 $264,000
Q3 2018

Nov 14, 2018
SELL
$11.85 - $16.0 $10,345 - $13,968
-873 Reduced 2.54%
33,562 $416,000
Q2 2018

Aug 14, 2018
BUY
$15.15 - $20.75 $521,690 - $714,526
34,435 New
34,435 $525,000
Q4 2017

Feb 14, 2018
SELL
$17.3 - $24.08 $201,942 - $281,085
-11,673 Closed
0 $0
Q3 2017

Nov 13, 2017
BUY
$15.2 - $21.5 $177,429 - $250,969
11,673
11,673 $251,000

Others Institutions Holding DVAX

# of Institutions
274
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.57B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email